SGLT2 inhibitors for type 2 diabetesWhat will be the likely therapeutic niche for sodium glucose cotransporter (SGLT2) inhibitors in the management of type 2 diabetes? ACC: Be mindful of heart failure risk with diabetes treatmentsMeta-analysis encompasses drug classes and glucose-lowering strategies. Clinical Q&A: Changing the course of type 2 diabetes New treatment strategies aim to reverse beta-cell dysfunction Family doctor from the same ethnic group associated with better quality of diabetes care for Chinese but not South Asian patients Marvel's Iron Man becomes a 'diabetes hero' New educational initiative from Siemens to engage pediatric and adolescent patients Forxiga: new “flozin” for type 2 diabetes Second SGLT2 inhibitor reaches Canadian market. Diabetes: Tight control extends life Drug helps preserve beta-cell function in type 2 diabetes But beneficial effect is lost once medication is stopped Hypoglycemia: Emergency care varies Study suggests need for guidelines and improved discharge planning Ask the Diabetes Expert: Metformin What’s your opinion on metformin given to diabetic patient with eGFR lower than 50ml/min? First Previous 37 38 39 40 41 Next Last
